https://www.selleckchem.com/pr....oducts/seclidemstat.
Children with neuromuscular disorders have been assumed to be a particularly vulnerable population since the beginning of COVID-19. Although this is a plausible hypothesis, there is no evidence that complications or mortality rates in neuromuscular patients are higher than in the general population. The aim of this study is to describe the clinical characteristics and outcome of COVID-19 in children with neuromuscular disorders. A registry of children with neuromuscular conditions and laboratory-confirmed-SARS-CoV-2 infection was s
Like
Comment
Share
